Skip to main content

Department

Toxicology

Preferred Sample Type

Buprenorphine & Norbuprenorphine

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
500 ul of serum/plasma

Specimen Transport

Usual

Sample Processing in Laboratory

Centrifuge and place in toxicology box in cold room.

Sample Preparation

Centrifuge

Turnaround Time

3 working days

Sample Stability

4 ºC

Buprenorphine & Norbuprenorphine

General Information

Buprenorphine (Buprenex, Buprex, Subutex, Transtec, ingredient of Suboxone) is a synthetic thebaine derivative that has both analgesic and opiod antagonist properties. As an analgesic, it is about 25 to 40 times more potent than morphine. When used as an antagonist is is equivalent in potency to naltrexone. The usual dose is 0.3 - 0.6 mg given parenterally, or 0.2 - 0.4 mg by the sublingual route every 6 - 8 hours. A transdermal patch, supplying 35 - 70 ug/hr over 3 days has been approved for the treatment of moderate to severe chronic pain.

Symptoms of buprenorphine overdosage include confusion, dizziness, miosis, hallucinations, hypotension, respiratory difficulty, seizures and coma.

Patient Preparation

For TDM, sample should be taken prior to dose. If toxicity is suspected, take sample at earliest opportunit

Notes

Please avoid use of gel seperator tubes.

Analysed by LC-MS/MS

Reference Range

0.5 - 10 ug/L

Specifications

  • EQA Scheme?: Yes
  • EQA Status: LGC QUARTZ, LGC CLIN TOX